Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Müllerian duct tissue consists of paired embryonic structures (the Müllerian/paramesonephric ducts) that develop early in fetal life and differentiate into the female reproductive tract, specifically the fallopian tubes, uterus, cervix, and upper vagina. In males, these ducts regress under the influence of anti-Müllerian hormone (AMH), but in females, they persist and form organs necessary for female fertility and pregnancy. The tissue is made up of both epithelial and mesenchymal cell layers and is regulated by complex developmental signaling pathways, including Wnt/β-catenin, LHX1, and various transcription factors. Anomalies in the formation, fusion, or resorption of these ducts can result in congenital defects such as uterine aplasia, bicornuate uterus, or septate uterus, often associated with infertility or reproductive complications. This is not a discrete protein, receptor, or single molecular entity, but a developmental tissue composed of many cell types and pathways.
null
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Müllerian duct tissue (null).